Table 1.
Clinical characteristics of 190 epithelial ovarian cancer cases from the Vanderbilt TROC
Characteristic | N or mean | % or std. dev |
---|---|---|
Age at Diagnosis, years | 57.9 | (13.7) |
Overall Survival, years | 4.3 | (3.4) |
Disease-Free Survival, years | 3.9 | (3.4) |
Race | ||
White | 168 | (88.4) |
African American | 11 | (5.8) |
Other/Unknown | 11 | (5.8) |
Histologic Subtype | ||
Serous | 131 | (69.0) |
Endometrioid | 25 | (13.2) |
Mucinous | 14 | (7.4) |
Clear Cell | 9 | (4.7) |
Mixed | 6 | (3.2) |
Other | 5 | (2.6) |
Stage | ||
I | 50 | (26.3) |
II | 7 | (3.7) |
III | 110 | (57.9) |
IV | 21 | (11.1) |
Unstaged | 2 | (1.1) |
Grade | ||
Low Grade | 33 | (17.4) |
High Grade | 157 | (82.6) |
Tumor Type | ||
Type I | 65 | (34.2) |
Type II | 125 | (65.8) |
Residual Disease | ||
Optimal Debulking | 47 | (24.7) |
Suboptimal Debulking | 89 | (46.8) |
Unknown or Not Applicable | 54 | (28.4) |
Platinum Sensitive Disease | ||
Resistant | 39 | (20.5) |
Sensitive | 81 | (42.6) |
Unknown or Not Applicable | 70 | (36.8) |
Percentages may not sum to 100 due to rounding error